0001104659-21-130022.txt : 20211026
0001104659-21-130022.hdr.sgml : 20211026
20211026170105
ACCESSION NUMBER: 0001104659-21-130022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211026
FILED AS OF DATE: 20211026
DATE AS OF CHANGE: 20211026
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clancy Paul J
CENTRAL INDEX KEY: 0001409601
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 211349378
MAIL ADDRESS:
STREET 1: C/O BIOGEN IDEC INC.
STREET 2: 14 CAMBRIDGE CENTER
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
tm2130646-19_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-10-26
0
0001840233
Xilio Therapeutics, Inc.
XLO
0001409601
Clancy Paul J
C/O XILIO THERAPEUTICS, INC.
828 WINTER STREET, SUITE 300
WALTHAM
MA
02451
1
0
0
0
Stock Option (right to buy)
5.51
2021-10-26
4
A
0
44033
0.00
A
2030-07-22
Common Stock
44033
44033
D
Stock Option (right to buy)
5.89
2021-10-26
4
A
0
65528
0.00
A
2021-03-10
Common Stock
65528
65528
D
On July 23, 2020, the reporting person was granted an option to purchase 44,033 shares of common stock of the Company, the vesting of which was contingent upon the closing of the Company's initial public offering ("IPO"). The Company's IPO closed as of October 26, 2021. On October 26, 2021, 13,760 shares underlying the award vested and the remainder will vest in equal monthly installments until July 16, 2024.
On March 11, 2021, the reporting person was granted an option to purchase 65,528 shares of common stock of the Company, the vesting of which was contingent upon the closing of the Company's IPO. The Company's IPO closed as of October 26, 2021. On October 26, 2021, 20,477 shares underlying the option vested and the remainder will vest in equal monthly installments until July 16, 2024.
/s/ Chris Frankenfield attorney-in-fact for Paul Clancy
2021-10-25